A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy
Clinical trial NCT06642909 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06642909
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2027-03-31
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.